REFERENCES
- Kutluk MT, Yeşilipek A. Turkish National Pediatric Cancer Registry 2002–2008 (Turkish Pediatric Oncology Group and Turkish Pediatric Hematology Society). J Clin Oncol. 2013;31(suppl): 10067.
- Oschlies I, Klapper W, Zimmermann M, Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 2006;107(10):4047–4052.
- Jaffe E, Harris NL, Stein H, Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, Campo E, Harris NL, , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008:157–166.
- Burkhardt B, Zimmermann M, Oschlies I, The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39–49.
- Raetz E, Perkins S, Davenport V, Cairo MS. B large-cell lymphoma in children and adolescents. Cancer Treat Rev. 2003;29(2):91–98.
- Reiter A, Klapper W. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol. 2008;142(3):329–347.
- Smith MA, Seibel NL, Altekruse SF, Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28(15):2625–2634.
- Abdelhamid T, Samra M, Ramadan H, Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study. J Egyptian Nat Cancer Inst. 2011;23(1):17–24.
- Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Sem Oncol. 1980;7(3):332–339.
- Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Program. 2009;2009(1):523–531.
- Patte C, Auperin A, Michon J, The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97(11):3370–3379.
- Patte C, Auperin A, Gerrard M, Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109(7):2773–2780.
- Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assn. 1958;53(282):457–481.
- Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187–220.
- Gross TG, Perkins SL. Malignant non-Hodgkin lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:663–682.
- Mora J, Filippa DA, Thaler HT, Large cell non-Hodgkin lymphoma of childhood: analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center. Cancer. 2000;88(1):186–197.
- Cairo MS, Sposto R, Hoover-Regan M, Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol. 2003;72(1):53–63.
- Buyukpamukcu M. Non-Hodgkin's lymphomas. In: Voute T KC, Barret A, eds. Cancer in Children. 4th ed. Oxford, UK: Oxford University Press; 1998:119–136.
- Percy CL, Smith MA, Linet M, Lymphomas and reticuloendothelial neoplasms. In: Ries LAG, Smith MA, Gurney JG, eds. Cancer Incidence and Survival among Children and Adolescents. United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999:35–49.
- Woessmann W, Seidemann K, Mann G, The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105(3):948–958.
- Ribeiro RC, Steliarova-Foucher E, Magrath I, Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol. 2008;9(8):721–729.
- Ahmad N, Zaidi A, Badar F, Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin's lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country. Asia-Pacific J Clin Oncol. 2010;6(1):49–56.
- Moleti ML, Al-Hadad SA, Al-Jadiry MF, Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatr Blood Cancer. 2011;56(4):560–567.